ACP
Acuta Capital Partners’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-107,500
| Closed | -$1.92M | – | 34 |
|
|
2019
Q4 | $1.92M | Buy |
107,500
+82,500
| +330% | +$1.47M | 0.47% | 29 |
|
|
2019
Q3 | $290K | Sell |
25,000
-188,000
| -88% | -$2.18M | 0.21% | 28 |
|
|
2019
Q2 | $4.72M | Buy |
213,000
+7,500
| +4% | +$166K | 1.68% | 20 |
|
|
2019
Q1 | $5.88M | Buy |
205,500
+32,500
| +19% | +$930K | 2.8% | 13 |
|
|
2018
Q4 | $3.42M | Buy |
173,000
+44,156
| +34% | +$872K | 2.61% | 11 |
|
|
2018
Q3 | $2.85M | Buy |
+128,844
| New | +$2.85M | 1.02% | 18 |
|